The stability of the transformed state in vitro is intriguing and could allow for a double bind therapeutic strategy where the goal is to switch between cell states EMT-MET to keep the tumor from rapidly escaping targeted therapies, such as EGFR inhibitors. This evidence concerns the gene MET and neoplasm.